5 Einträge gefunden

1. Reduction of cisplatin dosage by ZD 1839.

   1. Hambek, Markus
   2. Baghi, Mehran
   3. Strebhardt, Klaus
   4. Strebhard, Klaus
   5. Baumann, Helena
   6. Gstöttner, Wolfgang
   7. Knecht, Rainald

   2005 - Forschungsinformationssystem des UKE
2. The efficacy of MRI with ultrasmall superparamagnetic iron oxide particles (USPIO) in head and neck cancers.

   1. Baghi, Mehran
   2. Mack, Martin G
   3. Hambek, Markus
   4. Rieger, Joerg
   5. Vogl, Thomas
   6. Gstoettner, Wolfgang
   7. Knecht, Rainald

   2005 - Forschungsinformationssystem des UKE
3. EGFR-antibody-supplemented TPF chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatment.

   1. Knecht, Rainald
   2. Peters, Silke
   3. Hambek, Markus
   4. Solbach, Christine
   5. Baghi, Mehran
   6. Gstöttner, Wolfgang

   2005 - Forschungsinformationssystem des UKE
4. Iressa (ZD 1839) inhibits phosphorylation of three different downstream signal transducers in head and neck cancer (SCCHN).

   1. Hambek, Markus
   2. Baghi, Mehran
   3. Baumaun, Helena
   4. Strebhardt, Klaus
   5. Strebhard, Klaus
   6. Adunka, Oliver
   7. Gstöttner, Wolfgang

   2005 - Forschungsinformationssystem des UKE
5. Patient-based cross-platform comparison of oligonucleotide microarray expression profiles.

   1. Schlingemann, Joerg
   2. Habtemichael, Negusse
   3. Ittrich, Carina
   4. Toedt, Grischa
   5. Kramer, Heidi
   6. Hambek, Markus
   7. Knecht, Rainald

   2005 - Forschungsinformationssystem des UKE